Diversified Trust Co Buys New Holdings in Bruker Corporation (NASDAQ:BRKR)

Diversified Trust Co purchased a new position in shares of Bruker Corporation (NASDAQ:BRKR) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 9,050 shares of the medical research company’s stock, valued at approximately $378,000.

Other institutional investors also recently bought and sold shares of the company. Pinnacle Bancorp Inc. purchased a new stake in shares of Bruker in the 1st quarter valued at $29,000. Wealthquest Corp acquired a new position in Bruker during the first quarter valued at $143,000. Lecap Asset Management Ltd. purchased a new stake in Bruker in the first quarter valued at $2,714,000. Rakuten Securities Inc. purchased a new stake in Bruker in the first quarter valued at $167,000. Finally, Wealth Enhancement Advisory Services LLC grew its position in Bruker by 81.2% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 29,826 shares of the medical research company’s stock worth $1,245,000 after purchasing an additional 13,367 shares during the period. 79.52% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research firms recently commented on BRKR. Bank of America dropped their target price on Bruker from $61.00 to $50.00 and set a “buy” rating on the stock in a report on Thursday, June 26th. The Goldman Sachs Group lowered their price objective on Bruker from $50.00 to $45.00 and set a “neutral” rating on the stock in a research report on Thursday, May 8th. Barclays dropped their price objective on shares of Bruker from $50.00 to $46.00 and set an “overweight” rating on the stock in a research note on Thursday, May 8th. Wells Fargo & Company decreased their target price on shares of Bruker from $75.00 to $60.00 and set an “overweight” rating for the company in a research note on Thursday, April 17th. Finally, Stifel Nicolaus lowered their price target on shares of Bruker from $57.00 to $48.00 and set a “hold” rating on the stock in a report on Thursday, May 8th. Six research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $52.89.

Insider Transactions at Bruker

In other Bruker news, CEO Frank H. Laukien bought 2,608 shares of the company’s stock in a transaction dated Friday, June 6th. The stock was acquired at an average price of $38.36 per share, with a total value of $100,042.88. Following the completion of the acquisition, the chief executive officer directly owned 38,462,171 shares of the company’s stock, valued at $1,475,408,879.56. This represents a 0.01% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 27.30% of the stock is currently owned by company insiders.

Bruker Stock Performance

BRKR opened at $41.20 on Tuesday. The firm’s fifty day simple moving average is $38.62 and its two-hundred day simple moving average is $46.30. Bruker Corporation has a 52-week low of $34.10 and a 52-week high of $72.94. The company has a market cap of $6.24 billion, a price-to-earnings ratio of 79.23, a PEG ratio of 2.81 and a beta of 1.16. The company has a quick ratio of 0.74, a current ratio of 1.57 and a debt-to-equity ratio of 1.13.

Bruker (NASDAQ:BRKR) last issued its quarterly earnings results on Wednesday, May 7th. The medical research company reported $0.47 earnings per share for the quarter, beating analysts’ consensus estimates of $0.46 by $0.01. Bruker had a net margin of 2.31% and a return on equity of 19.47%. The firm had revenue of $801.40 million for the quarter, compared to analyst estimates of $763.83 million. During the same period last year, the company posted $0.53 EPS. Bruker’s quarterly revenue was up 11.0% compared to the same quarter last year. Equities analysts anticipate that Bruker Corporation will post 2.69 earnings per share for the current fiscal year.

Bruker Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, June 27th. Shareholders of record on Monday, June 16th were issued a $0.05 dividend. The ex-dividend date of this dividend was Monday, June 16th. This represents a $0.20 dividend on an annualized basis and a yield of 0.49%. Bruker’s payout ratio is currently 38.46%.

Bruker Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.